OncoMatch/Clinical Trials/NCT07678489
Total en Bloc Urethra Preservation at Robot-assisted Prostatectomy IDEAL Stage 2a
Is NCT07678489 recruiting? Yes, currently enrolling (Jul 2026). This NA trial studies non-drug interventions for prostate cancer (localized), urinary incontinence (c61).
Prospective single-arm IDEAL stage 2a feasibility study of urethra-preserving RARP in localized prostate cancer.
Check if I qualifyExtracted eligibility criteria
Cancer type
Prostate Cancer
Disease stage
Excluded: Stage IV
Grade: ISUP grade 1, ISUP grade 2, ISUP grade 3 (ISUP)
Biopsy ISUP grade 1-3 (= Gleason 3+3 / 3+4 / 4+3); No Gleason pattern 5
Demographics
Prior therapy
Cannot have received: prostate therapy (laser enucleation, TURP, focal therapy)
No prior prostate therapy (laser enucleation, TURP, focal therapy)
Cannot have received: pelvic/prostate radiotherapy
No pelvic/prostate radiotherapy
Cannot have received: abdominal/rectal surgery
No prior abdominal/rectal surgery
Cannot have received: androgen-deprivation therapy
No prior (neoadjuvant) androgen-deprivation therapy
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Frequently asked questions
Is NCT07678489 currently recruiting?
Yes, this trial is currently recruiting patients.
Can patients have received prior systemic therapy?
No. This trial requires treatment-naive patients — prior systemic therapy is an exclusion criterion.
Is this trial open to female patients?
No. This trial enrolls male patients only.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages